Rocket One Inc. Common Stock (NASDAQ:RKTO) Stock Rating Upgraded by Wall Street Zen

Rocket One Inc. Common Stock (NASDAQ:RKTO) was upgraded by stock analysts at Wall Street Zen from a “strong sell” rating to a “sell” rating in a research note issued to investors on Saturday.

Separately, Weiss Ratings cut Rocket One Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday. One equities research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Rocket One Inc. Common Stock presently has a consensus rating of “Hold” and a consensus target price of $5.00.

Rocket One Inc. Common Stock Price Performance

Shares of Rocket One Inc. Common Stock stock opened at $0.76 on Friday. Rocket One Inc. Common Stock has a 1-year low of $0.49 and a 1-year high of $2.45. The company’s fifty day simple moving average is $1.03 and its 200-day simple moving average is $0.92. The stock has a market capitalization of $16.96 million, a PE ratio of -0.95 and a beta of 0.96.

Rocket One Inc. Common Stock (NASDAQ:RKTO) last posted its quarterly earnings data on Friday, May 15th. The company reported ($0.17) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.03).

Institutional Trading of Rocket One Inc. Common Stock

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Geode Capital Management LLC lifted its stake in shares of Rocket One Inc. Common Stock by 8.0% during the 2nd quarter. Geode Capital Management LLC now owns 122,575 shares of the company’s stock valued at $143,000 after buying an additional 9,071 shares in the last quarter. Lido Advisors LLC purchased a new stake in Rocket One Inc. Common Stock in the 3rd quarter worth $32,000. Kestra Private Wealth Services LLC purchased a new stake in Rocket One Inc. Common Stock in the 3rd quarter worth $51,000. Virtu Financial LLC bought a new stake in Rocket One Inc. Common Stock during the third quarter valued at about $184,000. Finally, Citadel Advisors LLC bought a new stake in Rocket One Inc. Common Stock during the third quarter valued at about $232,000. 7.08% of the stock is owned by hedge funds and other institutional investors.

About Rocket One Inc. Common Stock

Hoth Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the acquisition, licensing and development of novel therapies for dermatological, central nervous system and other debilitating conditions. The company’s strategy emphasizes in-licensing late preclinical or early clinical assets with promising pharmacological profiles and leveraging formulation science to optimize delivery. Core to its approach is the design of topical and localized administration platforms intended to enhance drug penetration, sustain release and reduce systemic exposure.

Hoth’s development pipeline encompasses multiple candidate programs addressing high-unmet-need areas such as atopic dermatitis, epidermolysis bullosa and oral mucositis.